PNC Financial Services Group
NBRV

PNC Financial Services Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

PNC Financial Services Group’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8
Closed -$4K – 4174
2019
Q3 		$4K Buy
+8
New +$4.51K ﹤0.01% 3791

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PNC Financial Services Group's NBRV Position: Q4 2019 in Review

PNC Financial Services Group sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2019, closing a stake of 8 shares — an estimated $4K sold.

PNC Financial Services Group first reported a position in NBRV in Q3 2019 and held it in 1 quarter. The position peaked at $4K in Q3 2019. 50 funds tracked by Wall St. Rank hold NBRV as of Q4 2019.

  • PNC Financial Services Group reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 8 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2019, an estimated $4K.
  • PNC Financial Services Group first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2019 and held it in 1 quarter.
  • PNC Financial Services Group's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $4K in Q3 2019.
  • 50 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2019.

Based on PNC Financial Services Group's 13F filing for Q4 2019, filed 7 Feb 2020.